- Home
- Medical news & Guidelines
- Anesthesiology
- Cardiology and CTVS
- Critical Care
- Dentistry
- Dermatology
- Diabetes and Endocrinology
- ENT
- Gastroenterology
- Medicine
- Nephrology
- Neurology
- Obstretics-Gynaecology
- Oncology
- Ophthalmology
- Orthopaedics
- Pediatrics-Neonatology
- Psychiatry
- Pulmonology
- Radiology
- Surgery
- Urology
- Laboratory Medicine
- Diet
- Nursing
- Paramedical
- Physiotherapy
- Health news
- Fact Check
- Bone Health Fact Check
- Brain Health Fact Check
- Cancer Related Fact Check
- Child Care Fact Check
- Dental and oral health fact check
- Diabetes and metabolic health fact check
- Diet and Nutrition Fact Check
- Eye and ENT Care Fact Check
- Fitness fact check
- Gut health fact check
- Heart health fact check
- Kidney health fact check
- Medical education fact check
- Men's health fact check
- Respiratory fact check
- Skin and hair care fact check
- Vaccine and Immunization fact check
- Women's health fact check
- AYUSH
- State News
- Andaman and Nicobar Islands
- Andhra Pradesh
- Arunachal Pradesh
- Assam
- Bihar
- Chandigarh
- Chattisgarh
- Dadra and Nagar Haveli
- Daman and Diu
- Delhi
- Goa
- Gujarat
- Haryana
- Himachal Pradesh
- Jammu & Kashmir
- Jharkhand
- Karnataka
- Kerala
- Ladakh
- Lakshadweep
- Madhya Pradesh
- Maharashtra
- Manipur
- Meghalaya
- Mizoram
- Nagaland
- Odisha
- Puducherry
- Punjab
- Rajasthan
- Sikkim
- Tamil Nadu
- Telangana
- Tripura
- Uttar Pradesh
- Uttrakhand
- West Bengal
- Medical Education
- Industry
Terbanafine effective against Tinea capitis due to Trichophyton tonsurans
Occipital scaly plaques and papules with concomitant non-scalp lesions are the most common clinical presentation of T. tonsurans tinea capitis. Oral terbinafine can be effectively used for the management of this condition. The clinical manifestations and treatment outcomes were published in the journal Mycoses.
There is an increasing epidemiological concern about Trichophyton tonsurans tinea capitis. Very few studies have described the clinical manifestations and treatment response among adults. Hence researchers conducted a study to assess the clinical manifestations and treatment outcomes of T. tonsurans tinea capitis among adults.
A retrospective cohort study was carried out among 111 adults with T. tonsurans tinea capitis. Fungal culture or polymerase chain reaction was used to confirm the diagnosis. Examinees' demographics, disease characteristics, and treatment response were measured and the risk factors for the treatment failure were evaluated.
Results
- The mean age was 20.1 years (±3.1), with men (98.2%) outnumbering women.
- The follow-up lasted 12.2 months (±5.6).
- The occipital area (87.6%) was the major scalp area where T. tonsurans tinea capitis was seen.
- In 78.9% of the cases, the scalp manifestation was non-inflammatory with scaly plaques and papules seen in 76.1% and seborrhoea-like manifestations seen in 2.8%.
- 21.1% of cases presented with inflammatory tinea capitis with 10.1% as Kerion and 11% as pustular forms.
- Other than scalp areas were concomitantly involved. Tinea corporis was seen in 38.7% of the cases; tinea faciei and barbae in 24.3%; nape and anterior neck in 76.6% and 2.7% of the cases, respectively.
- There was an 83.2% clinical cure rate with an adequate treatment course of oral terbinafine.
- Treatment failure was significantly associated with concomitant tinea corporis (odds ratio 3.9; 95% confidence interval 1.3–12.1, p-Value< .02).
T. tonsurans tinea capitis included occipital scaly plaques and papules with concomitant non-scalp lesions and was effectively managed by Oral terbinafine but concomitant tinea corporis increased the risk for treatment failure.
Further reading: Galili E, Goldsmith T, Khanimov I, et al. Tinea capitis caused by Trichophyton tonsurans among adults: Clinical characteristics and treatment response [published online ahead of print, 2022 Oct 11]. Mycoses. 2022;10.1111/myc.13536. doi:10.1111/myc.13536
BDS, MDS
Dr.Niharika Harsha B (BDS,MDS) completed her BDS from Govt Dental College, Hyderabad and MDS from Dr.NTR University of health sciences(Now Kaloji Rao University). She has 4 years of private dental practice and worked for 2 years as Consultant Oral Radiologist at a Dental Imaging Centre in Hyderabad. She worked as Research Assistant and scientific writer in the development of Oral Anti cancer screening device with her seniors. She has a deep intriguing wish in writing highly engaging, captivating and informative medical content for a wider audience. She can be contacted at editorial@medicaldialogues.in.
Dr Kamal Kant Kohli-MBBS, DTCD- a chest specialist with more than 30 years of practice and a flair for writing clinical articles, Dr Kamal Kant Kohli joined Medical Dialogues as a Chief Editor of Medical News. Besides writing articles, as an editor, he proofreads and verifies all the medical content published on Medical Dialogues including those coming from journals, studies,medical conferences,guidelines etc. Email: drkohli@medicaldialogues.in. Contact no. 011-43720751